Literature DB >> 29170824

An analysis of the risk factors of anastomotic stricture after esophagectomy.

Koji Tanaka1, Tomoki Makino2, Makoto Yamasaki2, Takahiko Nishigaki2, Yasuhiro Miyazaki2, Tsuyoshi Takahashi2, Yukinori Kurokawa2, Kiyokazu Nakajima2, Shuji Takiguchi2, Masaki Mori2, Yuichiro Doki2.   

Abstract

PURPOSE: Anastomotic stricture after esophagectomy is a major cause of long-term morbidity and a poor quality of life. The aim of this study was to identify the risk factors for the development of anastomotic stricture after esophagectomy.
METHODS: The study subjects were 213 patients who underwent esophagectomy for squamous cell carcinoma of the esophagus between 2012 and 2014. Anastomotic stricture was defined as stenosis at the site of anastomosis that required endoscopic dilation. Refractory stricture was defined as that requiring more than four sessions of dilations. Univariate and multivariate logistic regression analyses were used to identify the potential risk factors for the development of anastomotic stricture.
RESULTS: In this retrospective study, 29 patients (13.6%) developed anastomotic stricture within a median period of 108 postoperative days and required a median of 2 dilations. Tumors located in the upper part of the esophagus (p = 0.004), the presence of cardiovascular disease (p = 0.024) and anastomotic leakage (p = 0.002) were identified as independent risk factors for the development of anastomotic stricture. The time to the diagnosis of refractory stricture (85 ± 33 days) was significantly shorter than that of non-refractory stricture (171 ± 22 days, p = 0.038).
CONCLUSIONS: Patients with squamous cell carcinoma in the upper esophagus with cardiovascular disease who develop postoperative anastomotic leakage should be carefully monitored to prevent the development of benign anastomotic stricture.

Entities:  

Keywords:  Anastomotic stricture; Esophageal cancer; Esophagectomy; Risk factor

Mesh:

Year:  2017        PMID: 29170824     DOI: 10.1007/s00595-017-1608-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer.

Authors:  Yusuke Yoda; Tomonori Yano; Kazuhiro Kaneko; Shinya Tsuruta; Yasuhiro Oono; Takashi Kojima; Keiko Minashi; Hiroaki Ikematsu; Atsushi Ohtsu
Journal:  Surg Endosc       Date:  2012-04-28       Impact factor: 4.584

Review 2.  Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy.

Authors:  Masayuki Watanabe; Shinji Mine; Koujiro Nishida; Takanori Kurogochi; Akihiko Okamura; Yu Imamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-27

3.  Impaired healing of cervical oesophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry.

Authors:  J P Pierie; P W De Graaf; H Poen; I Van der Tweel; H Obertop
Journal:  Eur J Surg       Date:  1994-11

4.  Clinical outcome of esophageal cancer patients with history of gastrectomy.

Authors:  Hiroshi Wada; Yuichiro Doki; Kiyonori Nishioka; Osamu Ishikawa; Toshiyuki Kabuto; Masahiko Yano; Morito Monden; Shingi Imaoka
Journal:  J Surg Oncol       Date:  2005-02-01       Impact factor: 3.454

5.  Risk Factors for Anastomotic Stricture Post-esophagectomy with a Standardized Sutured Anastomosis.

Authors:  Zuhair Ahmed; Jessie A Elliott; Sinead King; Claire L Donohoe; Narayanasamy Ravi; John V Reynolds
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

6.  Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis.

Authors:  Keishi Yamashita; Natsuya Katada; Hiromitsu Moriya; Kei Hosoda; Hiroaki Mieno; Chikatoshi Katada; Wasaburo Koizumi; Keika Hoshi; Masahiko Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-02-11

7.  Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery.

Authors:  G Petrin; A Ruol; G Battaglia; F Buin; S Merigliano; M Constantini; P Pavei; M Cagol; S Scappin; E Ancona
Journal:  Surg Endosc       Date:  2000-07       Impact factor: 4.584

8.  Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management.

Authors:  P Honkoop; P D Siersema; H W Tilanus; L P Stassen; W C Hop; M van Blankenstein
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

9.  The role of tissue ischemia in the pathogenesis of anastomotic stricture.

Authors:  R S Chung; D C Hitch; D N Armstrong
Journal:  Surgery       Date:  1988-11       Impact factor: 3.982

10.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  A L Ogilvie; M W Dronfield; R Ferguson; M Atkinson
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

View more
  13 in total

1.  Percutaneous transluminal plasty: a novel approach for refractory anastomotic stricture after esophagectomy.

Authors:  Naoya Yoshida; Takahiko Akiyama; Koichi Kinoshita; Yohei Nagai; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Ryuma Tokunaga; Keisuke Kosumi; Hideo Baba
Journal:  Esophagus       Date:  2018-08-09       Impact factor: 4.230

2.  Outcomes of Endoscopic Dilation in Patients with Esophageal Anastomotic Strictures: Comparison Between Different Etiologies.

Authors:  Rakesh Kochhar; Sarthak Malik; Yalaka Rami Reddy; Usha Dutta; Narendra Dhaka; Saroj Kant Sinha; Bipadabhanjan Mallick; T D Yadav; Vikas Gupta
Journal:  Dysphagia       Date:  2019-03-30       Impact factor: 3.438

3.  The Impact of Circular Stapler Size on the Incidence of Cervical Anastomotic Stricture After Esophagectomy.

Authors:  Takahiro Hosoi; Tetsuya Abe; Norihisa Uemura; Eiji Higaki; Ryosuke Kawai; Jiro Kawakami; Byonggu An; Masato Nagino; Yasuhiro Shimizu
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

4.  Endoscopic Vacuum Therapy in the Management of Postoperative Leakage After Esophagectomy.

Authors:  Jae Hyun Jeon; Hyo Joon Jang; Ji Eun Han; Young Soo Park; Yong Won Seong; Sukki Cho; Sanghoon Jheon; Kwhanmien Kim
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

5.  Risk factors associated with increased drainage volumes of chest tubes after transthoracic esophagectomy for esophageal cancer.

Authors:  Ryo Kato; Tomoki Makino; Makoto Yamasaki; Koji Tanaka; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Masaaki Motoori; Yutaka Kimura; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2019-07-24       Impact factor: 2.549

6.  The comparisons of three stapler placement methods for intrathoracic mechanistic circular stapling in Ivor Lewis minimally invasive esophagectomy.

Authors:  Bo Zhang; Zixiang Wu; Qi Wang; Saibo Pan; Lian Wang; Gang Shen; Huiping Chai; Ming Wu
Journal:  J Gastrointest Oncol       Date:  2021-10

7.  Population-based study of anastomotic stricture rates after minimally invasive and open oesophagectomy for cancer.

Authors:  O Helminen; V Kytö; J H Kauppila; J Gunn; J Lagergren; E Sihvo
Journal:  BJS Open       Date:  2019-06-10

8.  Fixed in the neck or pushed back into the thorax?-Impact of cervical anastomosis position on anastomosis healing.

Authors:  Jun Luo; Ze-Guo Zhuo; Yun-Ke Zhu; Han-Yu Deng; Tie-Niu Song; Gu-Ha Alai; Xu Shen; Yi-Dan Lin
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

9.  Anastomotic leakage after intrathoracic versus cervical oesophagogastric anastomosis for oesophageal carcinoma in Chinese population: a retrospective cohort study.

Authors:  Yin-Jiang Liu; Jun Fan; Huang-He He; Shu-Sheng Zhu; Qiu-Lan Chen; Rong-Hua Cao
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

10.  Risk factors for benign anastomotic stricture post-oesophagectomy: single-centre analysis of 702 oesophagectomies with squamous cell carcinoma.

Authors:  Yi-Min Gu; Yu-Shang Yang; Qi-Xin Shang; Wen-Ping Wang; Yong Yuan; Long-Qi Chen
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.